What is the address of APOCHEM?

The registered office of APOCHEM is located at Dorpsstraat 106, 8340 Damme.

Is APOCHEM still active?

Yes. According to the CBE (29 October 2026) APOCHEM is active, legal situation “Normale toestand”, started on 30 January 2003.

Is APOCHEM registered on Peppol?

Yes, APOCHEM is registered on the Peppol network with ID 0208:0479416560.

What is the enterprise number of APOCHEM?

The enterprise number of APOCHEM is BE0479416560.

When was APOCHEM founded?

APOCHEM was founded on 30 January 2003.

Who are the directors of APOCHEM?

According to the 2024 annual accounts, the directors of APOCHEM are: Jan Cordonnier, Anne Leenesonne.

Is APOCHEM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 January 2003; 4 annual accounts filed, latest fiscal year 2024; 2 directors known from the annual account.

How much profit did APOCHEM make in 2024?

APOCHEM recorded a loss after taxes of € 75,781 in financial year 2024.

What is the revenue of APOCHEM?

As a small company, APOCHEM is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 89,423.

How many employees does APOCHEM have?

According to the 2024 annual accounts, APOCHEM has 0 full-time equivalents (FTE).

Does APOCHEM have a website?

Yes, APOCHEM has a website at apotheekleenesonne.be.

APOCHEM (Public Limited) - Damme - BE0479416560

Q: What does APOCHEM do?

APOCHEM is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van public relations en communicatie. Public Limited, started on 30 January 2003, 1 establishment.

Dossier APOCHEM, printed on 29 October 2026 from databakkes.be/en/0479416560/apochem. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2023 and 2024.
Tight liquidity NBB

Cash and receivables cover 19 % of short-term debt in 2024; threshold 65 %.

Financials

Financial year 2024

APOCHEM from Damme, company number BE0479416560, closed financial year 2024 with a result of € -75,781 after tax. For that financial year APOCHEM recorded a gross margin of € 89,423 and equity of € 672,875. Compared with financial year 2023, the result moved from € -19,418 to € -75,781. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 18, 2025.

What it is worth Healthy

€ 672,875

▼ 10% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -75,781

▼ 290 % more loss than in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 66,756

▼ 20% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 160,875.

People and assets in 2024

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 30,251

▼ 41% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 13,066

▼ 63% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 7,335

▼ 44% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 217,757 Gross margin 2021: € 217,757 First fiscal year in the series	€ 256,526 Gross margin 2022: € 256,526 ▲ 18% vs 2021 (€ 217,757) Favourable step	€ 94,031 Gross margin 2023: € 94,031 ▼ 63% vs 2022 (€ 256,526) Unfavourable step	€ 89,423 Gross margin 2024: € 89,423 ▼ 5% vs 2023 (€ 94,031) Unfavourable step	▼ 5%
Profit after taxes	€ 13,738 Profit after taxes 2021: € 13,738 First fiscal year in the series	€ 88,525 Profit after taxes 2022: € 88,525 ▲ € 74,787 vs 2021 (€ 13,738) Favourable step	€ -19,418 Profit after taxes 2023: € -19,418 ▼ € 107,943 vs 2022 (€ 88,525) Unfavourable step	€ -75,781 Profit after taxes 2024: € -75,781 ▼ € 56,363 vs 2023 (€ -19,418) Unfavourable step	▼ € 56,363
Equity	€ 679,550 Equity 2021: € 679,550 First fiscal year in the series	€ 768,075 Equity 2022: € 768,075 ▲ 13% vs 2021 (€ 679,550) Favourable step	€ 748,656 Equity 2023: € 748,656 ▼ 3% vs 2022 (€ 768,075) Unfavourable step	€ 672,875 Equity 2024: € 672,875 ▼ 10% vs 2023 (€ 748,656) Unfavourable step	▼ 10%
Total debts	€ 1,859,702 Total debts 2021: € 1,859,702 First fiscal year in the series	€ 1,983,904 Total debts 2022: € 1,983,904 ▲ 7% vs 2021 (€ 1,859,702) Unfavourable step	€ 1,877,860 Total debts 2023: € 1,877,860 ▼ 5% vs 2022 (€ 1,983,904) Favourable step	€ 1,914,375 Total debts 2024: € 1,914,375 ▲ 2% vs 2023 (€ 1,877,860) Unfavourable step	▲ 2%
Cash	€ 86,842 Cash 2021: € 86,842 First fiscal year in the series	€ 305,130 Cash 2022: € 305,130 ▲ 251% vs 2021 (€ 86,842) Favourable step	€ 83,743 Cash 2023: € 83,743 ▼ 73% vs 2022 (€ 305,130) Unfavourable step	€ 66,756 Cash 2024: € 66,756 ▼ 20% vs 2023 (€ 83,743) Unfavourable step	▼ 20%
Land & buildings	€ 898,169 Land & buildings 2021: € 898,169 First fiscal year in the series	€ 838,399 Land & buildings 2022: € 838,399 ▼ 7% vs 2021 (€ 898,169) Unchanged	€ 837,921 Land & buildings 2023: € 837,921 Unchanged (€ 838,399) Unchanged	€ 799,751 Land & buildings 2024: € 799,751 ▼ 5% vs 2023 (€ 837,921) Unchanged	▼ 5%
Retained profit	€ 167,550 Retained profit 2021: € 167,550 First fiscal year in the series	€ 256,075 Retained profit 2022: € 256,075 ▲ 53% vs 2021 (€ 167,550) Favourable step	€ 236,656 Retained profit 2023: € 236,656 ▼ 8% vs 2022 (€ 256,075) Unfavourable step	€ 160,875 Retained profit 2024: € 160,875 ▼ 32% vs 2023 (€ 236,656) Unfavourable step	▼ 32%
Bank debt	€ 82,378 Bank debt 2021: € 82,378 First fiscal year in the series	€ 33,814 Bank debt 2022: € 33,814 ▼ 59% vs 2021 (€ 82,378) Favourable step	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 33,814) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 4,310,858 Balance sheet total 2021: € 4,310,858 First fiscal year in the series	€ 4,497,751 Balance sheet total 2022: € 4,497,751 ▲ 4% vs 2021 (€ 4,310,858) Unchanged	€ 4,268,454 Balance sheet total 2023: € 4,268,454 ▼ 5% vs 2022 (€ 4,497,751) Unchanged	€ 4,200,482 Balance sheet total 2024: € 4,200,482 ▼ 2% vs 2023 (€ 4,268,454) Unchanged	▼ 2%

Key figures of APOCHEM, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to APOCHEM?

What happened at APOCHEM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2026 Jan Cordonnier stepped down as director. NBB
2026 Anne Leenesonne stepped down as director. NBB
Jul 18, 2025 New annual accounts for financial year 2024: loss of € 75,781. Source: NBB ↗
2020 Anne Leenesonne became a director. NBB
2020 Jan Cordonnier became a director. NBB
Apr 7, 2003 New establishment in Damme. KBO
Jan 30, 2003 Start of the company according to the CBE. KBO

In short

From € 13,738 profit in 2021 to € 75,781 loss in 2024.

Paid € 20,889 in corporate taxes since 2021.

Best year ever: 2022, with € 88,525 profit.

Original PDFs at the National Bank ↗

Management

APOCHEM

Labotoxico NV 30%

It owns 30% of Labotoxico NV itself.

Directors

According to the 2024 annual accounts

Jan Cordonnier

Director

Also active at: Labotoxico, BIOCONTROL, V & V HOLDING COMPANY, Woonzorgcentrum Sint - Bernardus, CURANDO O.L.V. van 7 Weeën Ruiselede

since 2020 · until 2026

Anne Leenesonne

Director

Also active at: Labotoxico, Apotheek Leenesonne

since 2020 · until 2026

Establishments

Establishment units

Physical locations of this company

Registered office

Dorpsstraat 106

8340 Damme

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

BIOCONTROL same network

€ 15,161 gross margin · 2024

Apotheek Leenesonne same network

€ 595,872 gross margin · 2025

Linicor

€ 213,053 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheekleenesonne.be

Technologies

BootstrapChart.jsCloudflare CDNDiviElementorFont AwesomeGoogle AnalyticsGoogle FontsGravity FormsOwl CarouselPHPSwiperWP RocketWooCommerceWordPressYoast SEOjQueryjQuery UIlazysizesreCAPTCHA

Hosting & Email

Email provider

Self-hosted

Hosting

CLOUDFLARENET - Cloudflare, Inc., US

DNS

Cloudflare DNS

Website info

HTTPS Ja

Languages EN

Features

Webshop Blog Client portal Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ Load balancing

Details

Company number

0479.416.560

VAT number

BE 0479.416.560

Registered office

Dorpsstraat 106, 8340 Damme

Names & denominations

APOCHEM

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

30 January 2003

Peppol

Active · Active since 13 Oct 2025

Contact

apotheekleenesonne.be

Activities · NACE

Activiteiten van adviesbureaus op het gebied van public relations en communicatie

Public relationsbureaus

Adviesbureaus op het gebied van public relations en communicatie

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

APOCHEM

Warning lights

Financials

What happened to APOCHEM?

Management

Directors

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions